About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,342 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,342 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1121-1140 of 3,342 trials

Active not recruitingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyThe 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by…NCT03589339·San Francisco, California and 12 others WithdrawnAdjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyBackground: Most patients who have surgery for cancer that has metastasized (spread) to the lungs later get more metastases that cannot be treated with surgery or chemotherapy.NCT02839694

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

TerminatedPaclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV MelanomaRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00568451·Rochester, Minnesota

TerminatedCMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced MelanomaCMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monotherapy administered to participants with unresectable or…NCT04695977·Phoenix, Arizona and 19 others

Not yet recruitingLocoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver MetastasesEvaluate the safety and tolerability of treatment with autologous tumor infiltrating lymphocytes (TIL) administered via hepatic arterial infusion and preconditioning with…NCT05903937

RecruitingSun Exposure and Activities After Skin Cancer: Optimization of mHealth InterventionsThe purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors.NCT07556380·Chicago, Illinois and 1 other

CompletedSafety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic MelanomaPrimary objective: To evaluate the efficacy of two different dosing schedules of MS-275 in subjects with metastatic melanoma Secondary objectives: To evaluate the safety and to…NCT00185302

SuspendedMEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)Melanoma is one of the most common cutaneous cancers worldwide.NCT03932253·Beijing, Beijing Municipality

Active not recruitingExercise to Boost Response to Checkpoint Blockade ImmunotherapyThe purpose of this pilot study will be to provide i) information on feasibility implementing an exercise intervention trial among patients with cutaneous cancers, including…NCT06008977·Orlando, Florida

RecruitingPhase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)To determine the recommended Phase IIa dose (RP2D) of the triplet combination. To determine the safety and efficacy of the combination at the RP2D.NCT06683755·Houston, Texas

CompletedStudy of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or MelanomaThis clinical trial will evaluate the safety and feasibility of a humanized OX40 agonist, MEDI0562, in the pre-operative setting for patients with head and neck squamous cell…NCT03336606·Portland, Oregon

RecruitingThe Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid TumorsThe microbiome has the potential to serve as a robust biomarker of clinical response to immunotherapy.NCT05037825·Elizabethtown, Kentucky

CompletedUsing an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2The goal of this clinical trial is to explore feasibility, acceptability, and effectiveness of end-of-life conversation game "Hello" as a tool to help individuals with various…NCT06384417·Hershey, Pennsylvania

CompletedStudy of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced MalignanciesThe study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and…NCT04370704·Los Angeles, California and 16 others

CompletedEvaluation Of Mobile Gamma Camera Imaging For Sentinel Node Biopsy In MelanomaThis is a single-institution study seeking to evaluate if mobile gamma camera imaging can be used independent of standard fixed gamma camera imaging in patients undergoing…NCT01531608·Charlottesville, Virginia

TerminatedSafety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) MalignancyThe goal of this study is to find the maximum dose of a drug, temozolomide, that can safely be given to subjects with brain tumors.NCT00629187·Boston, Massachusetts

CompletedAn Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)This multi-center, prospective, observational safety study will evaluate the safety and effectiveness of Zelboraf (vemurafenib) in a real world setting.NCT01990248·Feldkirch and 79 others

CompletedTumor and Vaccine Site With a Toll Like Receptor (TLR) AgonistThe goal of this clinical research study is to learn if the vaccines, gp100(g209-2M), and MAGE-3, when given in combination with resiquimod (R848), can help to stimulate the…NCT00960752·Houston, Texas

CompletedA Phase I/II Study of Dasatinib and DacarbazineThe purpose of this study is to: Phase I Objectives: * Find the most tolerated dose to use for Phase II * Collect information on how the body responds to this combination of…NCT00597038·San Francisco, California and 1 other

CompletedInterest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot StudyMelanoma incidence is increasing in most developed countries. At the metastatic stage, the prognosis is usually poor.NCT02038348·Marseille

PreviousPage 57 of 168Next